UNC Chapel Hill — Chapel Hill, North Carolina

UNC Chapel Hill is a clinical research site located in Chapel Hill, North Carolina, United States 27599.

Crixeo Clinical Trials Trust Score: 32/100 (FAILING). This profile has not yet been claimed by the site owner.

UNC Chapel Hill has participated in 127 clinical trials with 32 currently active.

Therapeutic areas: Bladder Carcinoma, Ureter Carcinoma, Renal Pelvis Carcinoma.

Sponsors: Guardant Health, Inc., Duke University, Arginox Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Chapel Hill

Browse all research sites in North Carolina · View every site in Chapel Hill

Sponsor Feasibility Report

Trust Score: 32/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UNC Chapel Hill?

UNC Chapel Hill has a Crixeo Trust Score of 32/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UNC Chapel Hill conducted?

UNC Chapel Hill has 127 clinical trials on record, with 32 currently active. Their work covers Bladder Carcinoma, Ureter Carcinoma, Renal Pelvis Carcinoma.

Is UNC Chapel Hill accredited by Crixeo Clinical Trials?

UNC Chapel Hill has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UNC Chapel Hill?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.